ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS

被引：0
|
作者：
Pagan, F. [1 ]
Jost, W. H. [2 ]
Friedman, A. [3 ]
Michel, O. [4 ]
Oehlwein, C. [5 ]
Slawek, J. [6 ,7 ]
Bogucki, A. [8 ]
Ochudlo, S. [9 ,10 ]
Banach, M. [11 ]
Flatau-Baque, B. [12 ]
Csikos, J. [12 ]
Blitzer, A. [13 ,14 ,15 ]
机构：
[1] Georgetown Univ, Dept Neurol, Washington, DC USA
[2] Parkinson Klin Ortenau, Wolfach, Germany
[3] Med Univ Warsaw, Dept Neurol, Fac Hlth Sci, Warsaw, Poland
[4] Vrije Univ Brussel, Dept Otorhinolaryngol, Univ Hosp Brussels, Brussels, Belgium
[5] Neurol Outpatient Clin Parkinson Dis & Deep Brain, Gera, Germany
[6] Med Univ Gdansk, Dept Neurol Psychiat Nursing, Gdansk, Poland
[7] St Adalbert Hosp, Dept Neurol, Gdansk, Poland
[8] Med Univ Lodz, Dept Extrapyramidal Dis, Lodz, Poland
[9] Med Univ Silesia, Dept Neurol, Katowice, Poland
[10] Med Univ Silesia, Stroke Unit, Katowice, Poland
[11] Jagiellonian Univ, Dept Neurol, Coll Med, Krakow, Poland
[12] Merz Pharmaceut GmbH, Frankfurt, Germany
[13] Columbia Univ Coll Phys & Surg, Dept Otolaryngol Head & Neck Surg, 630 W 168th St, New York, NY 10032 USA
[14] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA
[15] NY Ctr Voice & Swallowing Disorders, New York, NY USA
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 293
引用
收藏
页码：E85 / E85
页数：1
相关论文
共 12 条
  • [1] ATTAINMENT OF PHYSIOLOGIC SALIVARY FLOW RATE WITH LONGTERM INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA IN PARKINSON'S DISEASE AND OTHER NEUROLOGIC CONDITIONS
    Jost, W.
    Pagan, F.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2023, 113 : 39 - 40
  • [2] Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions
    Pagan, F.
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    [J]. MOVEMENT DISORDERS, 2018, 33 : S754 - S754
  • [3] IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson's disease and other neurological conditions
    Jost, W.
    Pagan, F.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S453 - S454
  • [4] SIAXI: INCOBOTULINUMTOXINA FOR SIALORRHEA IN PARKINSON'S DISEASE, STROKE, AND OTHER ETIOLOGIES-PHASE 3 RESULTS
    Jost, Wolfgang
    Friedman, Andrzej
    Michel, Olaf
    Flatau-Baque, Birgit
    Hast, Michael
    Csikos, Janos
    Blitzer, Andrew
    [J]. MUSCLE & NERVE, 2018, 58 : S57 - S57
  • [5] SIAXI: IncobotulinumtoxinA for sialorrhea in Parkinson's disease, stroke, and other etiologies-Phase 3 Results
    Blitzer, Andrew
    Friedman, Andrzej
    Michel, Olaf
    Flatau-Baque, Birgit
    Csikos, Janos
    Jost, Wolfgang
    [J]. NEUROLOGY, 2018, 90
  • [6] MYSTICOL: A controlled study of Myobloc in the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions
    Hubble, J.
    Isaacson, S.
    Severt, L.
    Clinch, T.
    [J]. MOVEMENT DISORDERS, 2016, 31 (09) : E3 - E3
  • [7] SIAXI: Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of a Phase III, placebo-controlled, randomised, doubleblind study
    Csikos, J.
    Blitzer, A.
    Friedman, A.
    Michel, O.
    Flatau-Baque, B.
    Jost, W.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2018, 13 : 12 - 12
  • [8] SIAXI: Efficacy and safety of Xeomin (incobotulinumtoxinA) for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: Results of a Phase III, placebo-controlled, randomized, double-blind study
    Jost, Wolfgang
    Friedman, Andrzej
    Michel, Olaf
    Flatau-Baque, Birgit
    Csikos, Janos
    Blitzer, Andrew
    [J]. NEUROLOGY, 2018, 90
  • [9] MYSTICOL: A multisite, double-blind, randomized, placebo-controlled trial of rimabotulinumtoxinB for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions
    Isaacson, Stuart
    Jackson, Carlayne
    Molho, Eric
    Trosch, Richard
    Ondo, William
    Clinch, Thomas
    [J]. NEUROLOGY, 2017, 88
  • [10] Clinical efficacy of pramipexole in the treatment of conditions other than Parkinson's disease
    Becker, PM
    Corrigan, MH
    Kasper, S
    Lin, SC
    Montplaisir, J
    Szegedi, A
    Willner, P
    [J]. REVIEWS IN CONTEMPORARY PHARMACOTHERAPY, 2001, 12 (1-2): : 87 - 104
12